“In all honesty, we never met. I found out we were related through a complicated set of circumstances, but he was gone by then.”

“He was a lost soul and I wish we’d done better by him.”

“When did he enroll in the study?”

“Might have been March. He was hospitalized for acute alcohol poisoning. The social worker referred him after he’d been through detox and rehab. This was meant as long-term support.”

“So you felt he would benefit?”

“That was the hope. Do you know anything about the study?”

I shook my head, not wanting to interrupt the flow. He was already more forthcoming than I’d had reason to hope.

“We’re looking at the use of three drugs in combination, one of which, Glucotace, we’re especially interested in. When Terrence came into the program, we explained we were running a random double-blind study and couldn’t guarantee which group he’d be assigned to. One group is given the drug. The control group receives a placebo.”

“That’s actually one of the questions I had for you,” I said. “He seemed to think the medication made him sick.”

Dr. Reed said, “So I was told. He was convinced he was on Glucotace. This was week one when we were barely under way. Fifty-fifty chance of it. Subjects aren’t told what medication they’re taking. Those of us conducting the study also operate in the dark. That’s what the term ‘double-blind’ refers to.”

“Really. You didn’t know what he was taking?”

“I do now. I’m not sure how familiar you are with research strategies. Since I designed the study and applied for the grant, I have a rooting interest in the outcome, as you might imagine. If we both knew he was on Glucotace, it might influence the questions I asked and the answers he gave. Even if I knew what he was taking and he didn’t, the outcome could be affected. We’re all suggestible in one way or another. A patient taking a placebo might actually get better because that’s the nature of the beast. What we believe affects our physiology. If we’re anxious, our heart rate goes up. If we feel safe, our respiration slows.”

“I’ve experienced that myself,” I said.

“In a clinical trial, our job is to render an unbiased account of test results. Some of this is based on blood work and other screening procedures, but some of what we track are the subjective reports from the patients themselves.”

“If he complained, would you have looked into it?”

“Of course. Absolutely. As you may know, Terrence did complain and we undertook a review. He was seen by three other clinic doctors, and all of us kept a close eye on his lab values and conducted regular physical examinations. If he’d suffered serious side effects, the symptoms would have surfaced.”

“So there weren’t any?”